NEW YORK (GenomeWeb) – Singlera Genomics said today that it has raised $60 million in Series A+ financing led by Green Pine Capital Partners and Prosperico Ventures.

La Jolla, California- and Shanghai-based Singlera said that it will use the funds to help expand the development and commercialization of its non-invasive genetic tests for early-stage cancer detection and to fund clinical validation studies. The firm said that it will also use the funds to further expand its research facilities and its TitanSeq and Monod platforms into new product lines.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.